In terms of Regulation 47 of SEBI (LODR) Regulations, 2015, please find attached herewith the newspaper advertisement for the unaudited financial results for the quarter ended December 31, 2025.
BAYERCROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bayer CropScience has submitted copies of the newspaper advertisement (published on February 13, 2026 in Financial Express, Loksatta, Free Press Journal, and Navshakti) containing its unaudited financial results for Q3 FY26 and the nine months ended December 31, 2025. Revenue from operations for the quarter stood at Rs 1,106.2 crore versus Rs 1,057.4 crore in the year-ago quarter, a modest ~4.6% YoY rise. Net profit after tax jumped sharply to Rs 95.7 crore from Rs 34.2 crore in Q3 FY25, more than 2.8x growth. For the nine-month period, revenue rose to Rs 4,574.2 crore (from Rs 4,427 crore) and net profit grew to Rs 527.1 crore (from Rs 424.7 crore). EPS for the quarter was Rs 21.29 versus Rs 7.61 last year. The sharp sequential dip from Q2 (revenue Rs 1,553 crore, PAT Rs 152.7 crore) reflects normal seasonality in the agri-input business where Kharif sales peak in Q2.
Positive — strong YoY profit growth (nearly 3x in Q3) signals improved margins and pricing power; however, the sequential decline is seasonal and not a concern. This filing is a regulatory newspaper publication and contains no new information beyond what was already filed under Reg 33.